BlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust utilizes an option writing (selling) strategy to enhance dividend yield.
Company profile
Ticker
BME
Exchange
CEO
John Perlowski
Employees
Incorporated
Location
SEC CIK
Corporate docs
BME stock data
Latest filings (excl ownership)
N-CEN
Annual report (registered investment company)
14 Mar 24
N-CSR
Certified annual shareholder report (management investment company)
6 Mar 24
N-CSRS
Certified semi-annual shareholder report (management investment company)
1 Sep 23
N-PX
Annual report of proxy voting record
25 Aug 23
CORRESP
Correspondence with SEC
4 Aug 23
424B3
Prospectus supplement
26 Jun 23
DEF 14A
Definitive proxy
23 May 23
N-CEN
Annual report (registered investment company)
10 Mar 23
N-CSR
Certified annual shareholder report (management investment company)
7 Mar 23
424B3
Prospectus supplement
3 Jan 23
Latest ownership filings
NPORT-P
BlackRock Health Sciences Trust (Dec 2023 report)
26 Feb 24
4
Kyle McClements
2 Feb 24
4
H Erin Xie
2 Feb 24
4
Christopher Accettella
2 Feb 24
4
Xiang Liu
2 Feb 24
NPORT-P
BlackRock Health Sciences Trust (Sep 2023 report)
28 Nov 23
3
Arthur Philip Steinmetz
14 Sep 23
NPORT-P
BlackRock Health Sciences Trust (Jun 2023 report)
25 Aug 23
3
Aaron David Wasserman
6 Jul 23
NPORT-P
BlackRock Health Sciences Trust (Mar 2023 report)
26 May 23
Funds
Series | Ticker | %Monthly Return ? | $Assets | #Holdings | As of | ||
---|---|---|---|---|---|---|---|
BlackRock Health Sciences Trust | – | -0.01 | -0.46 | -2.67 | 582.39 mm | 328 | Sep 2023 |
Institutional ownership, Q3 2023
22.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 70 |
Opened positions | 8 |
Closed positions | 5 |
Increased positions | 25 |
Reduced positions | 21 |
13F shares | Current |
---|---|
Total value | 100.05 bn |
Total shares | 3.14 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
First Trust Portfolios | 433.39 k | $20.63 mm |
Nova R Wealth | 400.38 k | $15.67 bn |
WFC Wells Fargo & Co. | 355.50 k | $13.92 bn |
MS Morgan Stanley | 340.30 k | $13.32 bn |
IVZ Invesco | 184.52 k | $7.22 bn |
AMP Ameriprise Financial | 175.35 k | $6.86 bn |
BAC Bank Of America | 173.38 k | $6.79 bn |
UBS UBS Group AG - Registered Shares | 115.00 k | $4.50 bn |
RY Royal Bank Of Canada | 110.77 k | $4.34 bn |
Cornerstone Advisory | 102.88 k | $4.03 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 24 | Xiang Liu | Common Stock | Sale back to company | Dispose D | No | No | 41.48 | 188.518 | 7.82 k | 0 |
31 Jan 24 | Xiang Liu | Common Stock | Option exercise | Acquire M | No | No | 0 | 188.518 | 0.00 | 188.518 |
31 Jan 24 | Xiang Liu | Phantom Shares Common Stock | Option exercise | Dispose M | No | No | 0 | 102.402 | 0.00 | 102.402 |
31 Jan 24 | Xiang Liu | Phantom Shares Common Stock | Option exercise | Dispose M | No | No | 0 | 86.115 | 0.00 | 172.231 |
31 Jan 24 | Xiang Liu | Phantom Shares Common Stock | Grant | Acquire A | No | No | 41.48 | 223.828 | 9.28 k | 223.828 |
31 Jan 24 | Christopher Accettella | Common Stock | Sale back to company | Dispose D | No | No | 41.48 | 202.812 | 8.41 k | 769.576 |
31 Jan 24 | Christopher Accettella | Common Stock | Option exercise | Acquire M | No | No | 0 | 202.812 | 0.00 | 972.388 |
31 Jan 24 | Christopher Accettella | Phantom Shares Common Stock | Option exercise | Dispose M | No | No | 0 | 69.41 | 0.00 | 0 |
31 Jan 24 | Christopher Accettella | Phantom Shares Common Stock | Option exercise | Dispose M | No | No | 0 | 78.369 | 0.00 | 78.369 |
31 Jan 24 | Christopher Accettella | Phantom Shares Common Stock | Option exercise | Dispose M | No | No | 0 | 55.032 | 0.00 | 110.065 |
Press releases
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
1 Apr 24
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
28 Mar 24
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
1 Mar 24
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
29 Feb 24
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
1 Feb 24